| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kinetochores | 42 | 2013 | 172 | 4.400 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 12 | 2017 | 195 | 2.650 |
Why?
|
| Models, Biological | 47 | 2022 | 9464 | 2.300 |
Why?
|
| Software | 22 | 2024 | 4464 | 2.070 |
Why?
|
| Drug Discovery | 10 | 2023 | 1065 | 2.070 |
Why?
|
| Single-Cell Analysis | 21 | 2024 | 2535 | 1.950 |
Why?
|
| Chromosome Segregation | 18 | 2011 | 230 | 1.940 |
Why?
|
| Apoptosis | 30 | 2023 | 9514 | 1.710 |
Why?
|
| Signal Transduction | 63 | 2024 | 23618 | 1.690 |
Why?
|
| Neoplasms | 35 | 2024 | 22350 | 1.680 |
Why?
|
| Saccharomyces cerevisiae | 38 | 2013 | 2678 | 1.660 |
Why?
|
| Melanoma | 14 | 2024 | 5702 | 1.620 |
Why?
|
| Antineoplastic Agents | 27 | 2024 | 13644 | 1.570 |
Why?
|
| Drug Resistance, Neoplasm | 20 | 2024 | 5330 | 1.530 |
Why?
|
| Computational Biology | 24 | 2024 | 3564 | 1.530 |
Why?
|
| Protein Kinase Inhibitors | 24 | 2024 | 5690 | 1.510 |
Why?
|
| Chromosomal Instability | 4 | 2017 | 176 | 1.470 |
Why?
|
| Proto-Oncogene Proteins B-raf | 6 | 2023 | 2056 | 1.470 |
Why?
|
| Microscopy, Fluorescence | 9 | 2018 | 2629 | 1.380 |
Why?
|
| Cell Line, Tumor | 57 | 2024 | 17089 | 1.330 |
Why?
|
| MAP Kinase Signaling System | 9 | 2023 | 1492 | 1.230 |
Why?
|
| Microtubules | 25 | 2011 | 1063 | 1.210 |
Why?
|
| Saccharomyces cerevisiae Proteins | 25 | 2013 | 1836 | 1.200 |
Why?
|
| Fungal Proteins | 15 | 2009 | 901 | 1.160 |
Why?
|
| Tumor Microenvironment | 19 | 2024 | 3942 | 1.150 |
Why?
|
| Chromosomes, Fungal | 10 | 2013 | 110 | 1.130 |
Why?
|
| Data Mining | 3 | 2023 | 560 | 1.110 |
Why?
|
| Protein Kinases | 14 | 2024 | 1610 | 1.080 |
Why?
|
| Cell Cycle Proteins | 22 | 2020 | 3440 | 1.060 |
Why?
|
| Small Molecule Libraries | 5 | 2019 | 741 | 1.000 |
Why?
|
| Systems Biology | 11 | 2019 | 481 | 1.000 |
Why?
|
| Proteins | 16 | 2024 | 6002 | 0.990 |
Why?
|
| Cell Survival | 19 | 2022 | 5749 | 0.910 |
Why?
|
| High-Throughput Screening Assays | 7 | 2022 | 938 | 0.890 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2021 | 8623 | 0.880 |
Why?
|
| Image Processing, Computer-Assisted | 9 | 2024 | 8928 | 0.840 |
Why?
|
| Natural Language Processing | 3 | 2023 | 1203 | 0.840 |
Why?
|
| Mitosis | 12 | 2011 | 1176 | 0.830 |
Why?
|
| Caspases | 9 | 2023 | 881 | 0.820 |
Why?
|
| Respiratory Protective Devices | 2 | 2021 | 47 | 0.790 |
Why?
|
| Quality Control | 1 | 2024 | 834 | 0.770 |
Why?
|
| Dose-Response Relationship, Drug | 14 | 2020 | 10745 | 0.770 |
Why?
|
| Cell Proliferation | 13 | 2024 | 10451 | 0.760 |
Why?
|
| Caspase 8 | 6 | 2015 | 198 | 0.760 |
Why?
|
| Indoles | 4 | 2019 | 1834 | 0.750 |
Why?
|
| Systems Theory | 3 | 2019 | 57 | 0.740 |
Why?
|
| Microscopy | 9 | 2022 | 902 | 0.730 |
Why?
|
| Ecosystem | 2 | 2022 | 490 | 0.710 |
Why?
|
| Biophysics | 1 | 2021 | 376 | 0.690 |
Why?
|
| Humans | 204 | 2024 | 766812 | 0.690 |
Why?
|
| Epidermal Growth Factor | 8 | 2022 | 697 | 0.690 |
Why?
|
| Genes, cdc | 6 | 2005 | 113 | 0.680 |
Why?
|
| Receptors, Nerve Growth Factor | 2 | 2021 | 199 | 0.680 |
Why?
|
| DNA, Fungal | 10 | 2007 | 275 | 0.680 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2020 | 161 | 0.670 |
Why?
|
| Drug Screening Assays, Antitumor | 4 | 2020 | 718 | 0.660 |
Why?
|
| HeLa Cells | 22 | 2017 | 3073 | 0.660 |
Why?
|
| Cyclin-Dependent Kinase 4 | 3 | 2021 | 562 | 0.650 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2019 | 352 | 0.650 |
Why?
|
| Ovarian Neoplasms | 10 | 2024 | 4903 | 0.640 |
Why?
|
| Proto-Oncogene Proteins c-akt | 11 | 2024 | 2456 | 0.630 |
Why?
|
| Hepatocytes | 6 | 2017 | 1246 | 0.630 |
Why?
|
| Aneuploidy | 3 | 2014 | 573 | 0.620 |
Why?
|
| Ubiquitin | 2 | 2022 | 841 | 0.610 |
Why?
|
| Fluorescent Antibody Technique | 8 | 2024 | 2470 | 0.610 |
Why?
|
| Naphthyridines | 2 | 2019 | 184 | 0.600 |
Why?
|
| Protein Array Analysis | 3 | 2012 | 399 | 0.600 |
Why?
|
| Heat-Shock Proteins | 9 | 2020 | 792 | 0.600 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2024 | 3605 | 0.600 |
Why?
|
| Computer Simulation | 20 | 2019 | 6258 | 0.590 |
Why?
|
| Sulfonamides | 3 | 2017 | 1982 | 0.590 |
Why?
|
| Synovial Fluid | 2 | 2018 | 391 | 0.590 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2021 | 2952 | 0.580 |
Why?
|
| Trust | 1 | 2022 | 532 | 0.570 |
Why?
|
| Tumor Necrosis Factor-alpha | 9 | 2024 | 4349 | 0.560 |
Why?
|
| Animals | 82 | 2024 | 168939 | 0.560 |
Why?
|
| Programming Languages | 3 | 2013 | 133 | 0.560 |
Why?
|
| Zearalenone | 1 | 2016 | 3 | 0.560 |
Why?
|
| Computers | 1 | 2019 | 589 | 0.550 |
Why?
|
| Cell Physiological Phenomena | 4 | 2020 | 149 | 0.540 |
Why?
|
| Kinetics | 15 | 2022 | 6288 | 0.530 |
Why?
|
| Phosphatidylinositol 3-Kinases | 7 | 2024 | 2882 | 0.530 |
Why?
|
| Drug Evaluation, Preclinical | 6 | 2018 | 1331 | 0.530 |
Why?
|
| Nuclear Proteins | 16 | 2011 | 5795 | 0.530 |
Why?
|
| Staining and Labeling | 3 | 2022 | 1075 | 0.520 |
Why?
|
| Models, Genetic | 2 | 2017 | 3446 | 0.520 |
Why?
|
| Proteomics | 15 | 2024 | 3915 | 0.520 |
Why?
|
| Breast Neoplasms | 15 | 2024 | 21162 | 0.520 |
Why?
|
| Centromere | 8 | 2007 | 214 | 0.510 |
Why?
|
| Artifacts | 1 | 2024 | 1897 | 0.510 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2017 | 562 | 0.510 |
Why?
|
| Cell Cycle | 7 | 2022 | 2925 | 0.500 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 6 | 2022 | 11876 | 0.490 |
Why?
|
| Skin Neoplasms | 5 | 2023 | 5860 | 0.480 |
Why?
|
| Clinical Trials, Phase III as Topic | 2 | 2022 | 878 | 0.480 |
Why?
|
| Fibroblasts | 6 | 2024 | 4166 | 0.480 |
Why?
|
| Combined Modality Therapy | 4 | 2022 | 8540 | 0.480 |
Why?
|
| Enzyme Activation | 6 | 2012 | 3587 | 0.470 |
Why?
|
| Synovial Membrane | 2 | 2022 | 536 | 0.470 |
Why?
|
| Glioblastoma | 5 | 2024 | 3458 | 0.470 |
Why?
|
| Cell Death | 5 | 2024 | 1676 | 0.460 |
Why?
|
| Lymphoma, T-Cell | 1 | 2017 | 308 | 0.460 |
Why?
|
| Cell Division | 6 | 2020 | 4473 | 0.460 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 4 | 2023 | 635 | 0.460 |
Why?
|
| Proteome | 2 | 2019 | 1894 | 0.460 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 2 | 2011 | 61 | 0.460 |
Why?
|
| Microtubule-Associated Proteins | 5 | 2009 | 1073 | 0.450 |
Why?
|
| Pharmacogenetics | 2 | 2021 | 682 | 0.450 |
Why?
|
| Caspase 3 | 3 | 2011 | 730 | 0.450 |
Why?
|
| Occupational Exposure | 2 | 2021 | 1807 | 0.450 |
Why?
|
| Saccharomycetales | 3 | 2011 | 74 | 0.440 |
Why?
|
| Apoptosis Regulatory Proteins | 4 | 2013 | 1150 | 0.440 |
Why?
|
| Databases, Protein | 4 | 2021 | 390 | 0.440 |
Why?
|
| User-Computer Interface | 3 | 2019 | 1409 | 0.430 |
Why?
|
| Stochastic Processes | 2 | 2013 | 359 | 0.430 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 4 | 2013 | 1621 | 0.430 |
Why?
|
| DNA-Binding Proteins | 17 | 2012 | 9613 | 0.420 |
Why?
|
| Lymphoma, B-Cell | 1 | 2019 | 945 | 0.420 |
Why?
|
| Research Design | 3 | 2022 | 6206 | 0.410 |
Why?
|
| Sequence Deletion | 1 | 2017 | 1494 | 0.410 |
Why?
|
| Receptors, Growth Factor | 1 | 2013 | 324 | 0.410 |
Why?
|
| Neurogenesis | 1 | 2019 | 863 | 0.400 |
Why?
|
| Cell Line | 17 | 2023 | 15564 | 0.400 |
Why?
|
| Microchip Analytical Procedures | 3 | 2008 | 28 | 0.400 |
Why?
|
| Neural Stem Cells | 2 | 2019 | 895 | 0.390 |
Why?
|
| Cyclin-Dependent Kinases | 3 | 2021 | 661 | 0.390 |
Why?
|
| Drug Therapy, Combination | 5 | 2024 | 6306 | 0.390 |
Why?
|
| Cell Biology | 1 | 2012 | 91 | 0.380 |
Why?
|
| Calcium-Binding Proteins | 6 | 2011 | 1080 | 0.380 |
Why?
|
| Drug Synergism | 5 | 2024 | 1757 | 0.380 |
Why?
|
| Clinical Trials as Topic | 4 | 2022 | 8045 | 0.380 |
Why?
|
| Models, Theoretical | 5 | 2016 | 3563 | 0.380 |
Why?
|
| Nerve Tissue Proteins | 3 | 2021 | 4401 | 0.370 |
Why?
|
| Carrier Proteins | 6 | 2005 | 4926 | 0.370 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2018 | 1657 | 0.360 |
Why?
|
| Biochemistry | 2 | 2011 | 115 | 0.360 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 4 | 2023 | 616 | 0.360 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 384 | 0.360 |
Why?
|
| Oncogenes | 4 | 2023 | 1232 | 0.350 |
Why?
|
| Software Design | 1 | 2011 | 173 | 0.350 |
Why?
|
| Chromosomes | 4 | 2007 | 578 | 0.350 |
Why?
|
| Mutation | 20 | 2023 | 30214 | 0.350 |
Why?
|
| Pharmacology, Clinical | 1 | 2010 | 23 | 0.350 |
Why?
|
| Database Management Systems | 2 | 2011 | 263 | 0.350 |
Why?
|
| Biochemical Phenomena | 1 | 2010 | 58 | 0.350 |
Why?
|
| Adaptation, Physiological | 2 | 2020 | 1312 | 0.350 |
Why?
|
| Computer Graphics | 2 | 2022 | 345 | 0.350 |
Why?
|
| Schizosaccharomyces | 2 | 2011 | 236 | 0.350 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 1672 | 0.340 |
Why?
|
| Pharmacological Phenomena | 1 | 2009 | 11 | 0.340 |
Why?
|
| Plaque, Amyloid | 1 | 2014 | 769 | 0.340 |
Why?
|
| Phosphorylation | 16 | 2021 | 8310 | 0.340 |
Why?
|
| Cluster Analysis | 8 | 2019 | 2721 | 0.340 |
Why?
|
| Gene Expression Profiling | 13 | 2024 | 9528 | 0.330 |
Why?
|
| Mice | 35 | 2024 | 81898 | 0.330 |
Why?
|
| Oncogene Proteins v-erbB | 1 | 2009 | 17 | 0.320 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 8 | 2020 | 2887 | 0.320 |
Why?
|
| Cell Membrane | 2 | 2020 | 3642 | 0.320 |
Why?
|
| Fluorescent Dyes | 3 | 2015 | 1927 | 0.320 |
Why?
|
| Enzymes | 1 | 2010 | 254 | 0.320 |
Why?
|
| Mitochondrial Membranes | 4 | 2011 | 185 | 0.310 |
Why?
|
| Chromosomes, Human | 2 | 2011 | 437 | 0.310 |
Why?
|
| MAP Kinase Kinase Kinases | 3 | 2016 | 252 | 0.310 |
Why?
|
| Cells | 1 | 2009 | 162 | 0.300 |
Why?
|
| Myeloid Cells | 2 | 2024 | 838 | 0.300 |
Why?
|
| Molecular Motor Proteins | 2 | 2006 | 105 | 0.300 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2022 | 3788 | 0.300 |
Why?
|
| Fuzzy Logic | 4 | 2012 | 58 | 0.290 |
Why?
|
| Antibodies | 3 | 2019 | 2421 | 0.290 |
Why?
|
| Research Personnel | 1 | 2012 | 589 | 0.290 |
Why?
|
| Information Dissemination | 1 | 2016 | 1142 | 0.290 |
Why?
|
| Pyrimidinones | 2 | 2020 | 385 | 0.290 |
Why?
|
| Mammals | 3 | 2023 | 1133 | 0.290 |
Why?
|
| Cytokines | 9 | 2022 | 7438 | 0.280 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 1882 | 0.280 |
Why?
|
| DNA Damage | 8 | 2023 | 2469 | 0.280 |
Why?
|
| Stress, Physiological | 1 | 2014 | 1407 | 0.280 |
Why?
|
| Luminescent Proteins | 4 | 2008 | 839 | 0.270 |
Why?
|
| Yeasts | 4 | 2003 | 278 | 0.270 |
Why?
|
| CD8-Positive T-Lymphocytes | 8 | 2024 | 4652 | 0.270 |
Why?
|
| Antirheumatic Agents | 1 | 2016 | 1383 | 0.270 |
Why?
|
| Biological Products | 1 | 2016 | 948 | 0.270 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 582 | 0.270 |
Why?
|
| Cytosol | 4 | 2018 | 887 | 0.260 |
Why?
|
| BRCA1 Protein | 3 | 2022 | 1155 | 0.260 |
Why?
|
| HEK293 Cells | 6 | 2020 | 4277 | 0.260 |
Why?
|
| Gene Regulatory Networks | 4 | 2021 | 1752 | 0.260 |
Why?
|
| Autocrine Communication | 2 | 2006 | 168 | 0.260 |
Why?
|
| Adenomatous Polyposis Coli Protein | 2 | 2006 | 182 | 0.260 |
Why?
|
| Drug Industry | 1 | 2012 | 791 | 0.260 |
Why?
|
| Gene Expression Regulation, Fungal | 4 | 2009 | 496 | 0.260 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2017 | 464 | 0.260 |
Why?
|
| Reproducibility of Results | 15 | 2023 | 20146 | 0.250 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3110 | 0.250 |
Why?
|
| Pyrazoles | 4 | 2020 | 2030 | 0.250 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2021 | 224 | 0.250 |
Why?
|
| Pandemics | 5 | 2021 | 8734 | 0.250 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3232 | 0.250 |
Why?
|
| Immunotherapy | 7 | 2024 | 4747 | 0.250 |
Why?
|
| Algorithms | 18 | 2024 | 14073 | 0.250 |
Why?
|
| Adenocarcinoma | 1 | 2023 | 6359 | 0.240 |
Why?
|
| Phosphotransferases | 2 | 2021 | 302 | 0.240 |
Why?
|
| Ubiquitination | 3 | 2022 | 1007 | 0.240 |
Why?
|
| Protein Conformation | 8 | 2024 | 3948 | 0.240 |
Why?
|
| Biological Transport | 3 | 2024 | 2083 | 0.240 |
Why?
|
| Bayes Theorem | 2 | 2013 | 2353 | 0.240 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2024 | 16 | 0.240 |
Why?
|
| Cysteine | 2 | 2020 | 896 | 0.230 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2020 | 2426 | 0.230 |
Why?
|
| Phosphoproteins | 8 | 2021 | 2448 | 0.230 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2020 | 2060 | 0.230 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 2329 | 0.230 |
Why?
|
| Amino Acid Transport Systems | 1 | 2024 | 34 | 0.230 |
Why?
|
| Genes | 4 | 1989 | 1824 | 0.230 |
Why?
|
| Pharmaceutical Preparations | 2 | 2011 | 1086 | 0.220 |
Why?
|
| Receptor, erbB-3 | 2 | 2017 | 141 | 0.220 |
Why?
|
| Diagnostic Imaging | 3 | 2023 | 3530 | 0.220 |
Why?
|
| Flow Cytometry | 6 | 2019 | 5890 | 0.220 |
Why?
|
| Chromatids | 2 | 2001 | 62 | 0.220 |
Why?
|
| Anaphase | 5 | 2013 | 112 | 0.220 |
Why?
|
| Information Storage and Retrieval | 3 | 2017 | 832 | 0.220 |
Why?
|
| Protein Binding | 15 | 2021 | 9326 | 0.210 |
Why?
|
| Cell Culture Techniques | 3 | 2019 | 1646 | 0.210 |
Why?
|
| Genomic Instability | 3 | 2021 | 716 | 0.210 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2024 | 303 | 0.210 |
Why?
|
| Protein Interaction Mapping | 4 | 2017 | 621 | 0.210 |
Why?
|
| Ketones | 1 | 2024 | 183 | 0.210 |
Why?
|
| Immunoconjugates | 2 | 2024 | 976 | 0.210 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 3 | 2007 | 170 | 0.210 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 6965 | 0.210 |
Why?
|
| Furans | 1 | 2024 | 199 | 0.210 |
Why?
|
| Endopeptidases | 2 | 2022 | 762 | 0.210 |
Why?
|
| Genes, Fungal | 3 | 1995 | 441 | 0.210 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2018 | 694 | 0.210 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2023 | 121 | 0.210 |
Why?
|
| Receptor, erbB-2 | 4 | 2020 | 2598 | 0.210 |
Why?
|
| Databases, Factual | 6 | 2023 | 8065 | 0.200 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2011 | 4047 | 0.200 |
Why?
|
| Molecular Sequence Data | 17 | 2009 | 17609 | 0.200 |
Why?
|
| Amino Acid Sequence | 17 | 2020 | 13411 | 0.200 |
Why?
|
| Enzyme Inhibitors | 5 | 2017 | 3723 | 0.200 |
Why?
|
| Macromolecular Substances | 7 | 2004 | 1431 | 0.200 |
Why?
|
| Brain Neoplasms | 2 | 2020 | 9101 | 0.200 |
Why?
|
| Tubulin Modulators | 3 | 2011 | 106 | 0.200 |
Why?
|
| Linear Models | 3 | 2019 | 5873 | 0.200 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2022 | 6514 | 0.200 |
Why?
|
| Gene Deletion | 3 | 2008 | 2669 | 0.200 |
Why?
|
| src Homology Domains | 3 | 2021 | 361 | 0.190 |
Why?
|
| Rhabdoid Tumor | 1 | 2024 | 211 | 0.190 |
Why?
|
| Hemangiosarcoma | 1 | 2024 | 214 | 0.190 |
Why?
|
| Circadian Clocks | 1 | 2024 | 168 | 0.190 |
Why?
|
| Thiolester Hydrolases | 1 | 2022 | 91 | 0.190 |
Why?
|
| Cells, Cultured | 10 | 2019 | 18986 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2015 | 1405 | 0.190 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 2 | 2013 | 88 | 0.190 |
Why?
|
| NF-kappa B | 3 | 2018 | 2493 | 0.190 |
Why?
|
| Liposarcoma | 1 | 2024 | 288 | 0.190 |
Why?
|
| Hidradenitis Suppurativa | 1 | 2024 | 176 | 0.180 |
Why?
|
| Data Interpretation, Statistical | 1 | 2011 | 2694 | 0.180 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 2902 | 0.180 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 456 | 0.180 |
Why?
|
| Mitochondrial Proteins | 2 | 2022 | 980 | 0.180 |
Why?
|
| Receptor, Insulin | 2 | 2019 | 839 | 0.180 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 2 | 2012 | 58 | 0.180 |
Why?
|
| Glutarates | 1 | 2022 | 242 | 0.180 |
Why?
|
| Macrophages | 8 | 2024 | 5784 | 0.180 |
Why?
|
| Models, Molecular | 5 | 2024 | 5388 | 0.180 |
Why?
|
| Decontamination | 1 | 2021 | 73 | 0.180 |
Why?
|
| Interleukin-4 | 1 | 2024 | 1156 | 0.180 |
Why?
|
| Ligands | 4 | 2022 | 3274 | 0.180 |
Why?
|
| Models, Statistical | 3 | 2022 | 5092 | 0.180 |
Why?
|
| Mice, Nude | 5 | 2019 | 3618 | 0.180 |
Why?
|
| Serine | 1 | 2024 | 828 | 0.180 |
Why?
|
| Lung Neoplasms | 8 | 2024 | 13489 | 0.180 |
Why?
|
| Knowledge Bases | 1 | 2021 | 96 | 0.170 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2023 | 9407 | 0.170 |
Why?
|
| Protein Transport | 3 | 2018 | 1944 | 0.170 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 1762 | 0.170 |
Why?
|
| Molecular Structure | 6 | 2020 | 1882 | 0.170 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2020 | 55 | 0.170 |
Why?
|
| Nociceptors | 1 | 2024 | 460 | 0.170 |
Why?
|
| Quinazolines | 3 | 2011 | 1367 | 0.170 |
Why?
|
| Protein Folding | 1 | 2024 | 869 | 0.170 |
Why?
|
| Phenotype | 12 | 2022 | 16722 | 0.170 |
Why?
|
| Sterilization | 1 | 2021 | 132 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 7 | 2021 | 6105 | 0.170 |
Why?
|
| Leiomyosarcoma | 1 | 2024 | 426 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2020 | 185 | 0.170 |
Why?
|
| Point-of-Care Systems | 1 | 2008 | 1217 | 0.170 |
Why?
|
| Cystadenoma, Serous | 1 | 2020 | 99 | 0.170 |
Why?
|
| Nootropic Agents | 1 | 2021 | 159 | 0.170 |
Why?
|
| Transcription Factor CHOP | 1 | 2019 | 69 | 0.170 |
Why?
|
| Female | 42 | 2024 | 396532 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2020 | 110 | 0.170 |
Why?
|
| Cell Movement | 3 | 2019 | 5204 | 0.160 |
Why?
|
| Karyotyping | 3 | 2014 | 1176 | 0.160 |
Why?
|
| Structure-Activity Relationship | 5 | 2020 | 3053 | 0.160 |
Why?
|
| Models, Chemical | 1 | 2021 | 607 | 0.160 |
Why?
|
| Sarcoma, Synovial | 1 | 2021 | 157 | 0.160 |
Why?
|
| Cell Line, Transformed | 2 | 2011 | 861 | 0.160 |
Why?
|
| Receptors, Somatomedin | 1 | 2019 | 57 | 0.160 |
Why?
|
| Chromosomal Proteins, Non-Histone | 5 | 2008 | 724 | 0.160 |
Why?
|
| Serotonin | 1 | 2024 | 1045 | 0.160 |
Why?
|
| Immune Evasion | 1 | 2023 | 375 | 0.160 |
Why?
|
| Palatine Tonsil | 1 | 2019 | 193 | 0.160 |
Why?
|
| Uveomeningoencephalitic Syndrome | 1 | 2019 | 22 | 0.160 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 2823 | 0.160 |
Why?
|
| Ventilators, Mechanical | 1 | 2021 | 292 | 0.160 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2022 | 951 | 0.160 |
Why?
|
| Acrylamide | 1 | 2019 | 59 | 0.160 |
Why?
|
| Cerebellar Neoplasms | 1 | 2024 | 588 | 0.160 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2022 | 456 | 0.160 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2019 | 92 | 0.160 |
Why?
|
| Pyrimidines | 4 | 2021 | 3043 | 0.160 |
Why?
|
| Drugs, Investigational | 1 | 2021 | 211 | 0.160 |
Why?
|
| Masks | 1 | 2021 | 212 | 0.160 |
Why?
|
| Acclimatization | 1 | 2019 | 113 | 0.160 |
Why?
|
| Green Fluorescent Proteins | 5 | 2011 | 2062 | 0.160 |
Why?
|
| Immunity | 2 | 2023 | 1002 | 0.150 |
Why?
|
| Ascites | 1 | 2020 | 336 | 0.150 |
Why?
|
| Stem Cell Niche | 1 | 2021 | 346 | 0.150 |
Why?
|
| Frontotemporal Dementia | 1 | 2021 | 249 | 0.150 |
Why?
|
| Cataloging | 1 | 2017 | 8 | 0.150 |
Why?
|
| Antigen-Presenting Cells | 1 | 2021 | 960 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3796 | 0.150 |
Why?
|
| RNA Interference | 5 | 2013 | 2829 | 0.150 |
Why?
|
| Inflammation | 5 | 2024 | 10863 | 0.150 |
Why?
|
| Extracellular Space | 1 | 2020 | 563 | 0.150 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2023 | 820 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2012 | 1965 | 0.150 |
Why?
|
| Transcription, Genetic | 8 | 2020 | 7612 | 0.150 |
Why?
|
| Amino Acids | 1 | 2024 | 1711 | 0.150 |
Why?
|
| Azepines | 1 | 2019 | 329 | 0.140 |
Why?
|
| Sirtuin 3 | 1 | 2018 | 66 | 0.140 |
Why?
|
| Meiosis | 2 | 2011 | 326 | 0.140 |
Why?
|
| Alzheimer Disease | 2 | 2021 | 8715 | 0.140 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2022 | 480 | 0.140 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2019 | 330 | 0.140 |
Why?
|
| Phosphotyrosine | 2 | 2021 | 458 | 0.140 |
Why?
|
| Uncertainty | 1 | 2022 | 765 | 0.140 |
Why?
|
| Hydrogen Peroxide | 1 | 2021 | 741 | 0.140 |
Why?
|
| src-Family Kinases | 1 | 2020 | 539 | 0.140 |
Why?
|
| Evolution, Molecular | 2 | 2021 | 1893 | 0.140 |
Why?
|
| Tumor Necrosis Factors | 2 | 2023 | 109 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2019 | 800 | 0.140 |
Why?
|
| Feedback, Physiological | 3 | 2009 | 481 | 0.140 |
Why?
|
| Time Factors | 10 | 2017 | 40149 | 0.140 |
Why?
|
| Drug Interactions | 2 | 2020 | 1419 | 0.140 |
Why?
|
| BRCA2 Protein | 1 | 2022 | 802 | 0.140 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2018 | 146 | 0.140 |
Why?
|
| Permeability | 2 | 2009 | 721 | 0.140 |
Why?
|
| Anilides | 1 | 2020 | 413 | 0.140 |
Why?
|
| Cell Nucleus | 2 | 2022 | 2875 | 0.140 |
Why?
|
| ras Proteins | 2 | 2020 | 1055 | 0.130 |
Why?
|
| Recombination, Genetic | 1 | 2021 | 1524 | 0.130 |
Why?
|
| Repressor Proteins | 6 | 2021 | 2979 | 0.130 |
Why?
|
| Skin | 3 | 2024 | 4499 | 0.130 |
Why?
|
| Neoplasm Transplantation | 2 | 2017 | 2012 | 0.130 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2019 | 385 | 0.130 |
Why?
|
| Protease Inhibitors | 1 | 2020 | 750 | 0.130 |
Why?
|
| Amides | 1 | 2019 | 451 | 0.130 |
Why?
|
| Hot Temperature | 4 | 1991 | 1441 | 0.130 |
Why?
|
| RNA | 3 | 2024 | 2715 | 0.130 |
Why?
|
| Brain Edema | 1 | 2020 | 601 | 0.130 |
Why?
|
| Base Sequence | 11 | 2016 | 12415 | 0.130 |
Why?
|
| Ubiquitins | 1 | 1997 | 365 | 0.130 |
Why?
|
| F-Box Proteins | 1 | 1997 | 199 | 0.130 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2024 | 5389 | 0.130 |
Why?
|
| Uveal Neoplasms | 1 | 2019 | 344 | 0.130 |
Why?
|
| Cricetulus | 1 | 2017 | 810 | 0.130 |
Why?
|
| Tumor Escape | 1 | 2018 | 371 | 0.130 |
Why?
|
| Nocodazole | 3 | 2011 | 95 | 0.130 |
Why?
|
| Chromosome Aberrations | 3 | 2014 | 1776 | 0.130 |
Why?
|
| Insulin | 5 | 2024 | 6608 | 0.120 |
Why?
|
| Craniopharyngioma | 1 | 2018 | 279 | 0.120 |
Why?
|
| Stromal Cells | 2 | 2018 | 1334 | 0.120 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2015 | 46 | 0.120 |
Why?
|
| Transcription Factors | 6 | 2021 | 12159 | 0.120 |
Why?
|
| Receptors, Death Domain | 1 | 2015 | 31 | 0.120 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2024 | 926 | 0.120 |
Why?
|
| Pattern Recognition, Automated | 1 | 2021 | 980 | 0.120 |
Why?
|
| Nucleotides | 1 | 2018 | 454 | 0.120 |
Why?
|
| T-Lymphocytes | 5 | 2023 | 10263 | 0.120 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2021 | 616 | 0.120 |
Why?
|
| CHO Cells | 1 | 2017 | 1376 | 0.120 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2014 | 1677 | 0.120 |
Why?
|
| Mitochondria | 4 | 2013 | 3678 | 0.120 |
Why?
|
| Lab-On-A-Chip Devices | 3 | 2008 | 426 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1144 | 0.120 |
Why?
|
| Cell Differentiation | 4 | 2024 | 11657 | 0.120 |
Why?
|
| Centrosome | 2 | 2008 | 209 | 0.120 |
Why?
|
| Cisplatin | 1 | 2020 | 1656 | 0.120 |
Why?
|
| Frizzled Receptors | 1 | 2014 | 86 | 0.120 |
Why?
|
| Endpoint Determination | 1 | 2017 | 592 | 0.120 |
Why?
|
| HT29 Cells | 5 | 2005 | 187 | 0.110 |
Why?
|
| Drug Delivery Systems | 3 | 2017 | 2210 | 0.110 |
Why?
|
| Thalidomide | 1 | 2019 | 886 | 0.110 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 956 | 0.110 |
Why?
|
| S Phase | 2 | 2013 | 424 | 0.110 |
Why?
|
| Genomics | 7 | 2024 | 5922 | 0.110 |
Why?
|
| Coloring Agents | 1 | 2016 | 565 | 0.110 |
Why?
|
| Leukemia | 1 | 2022 | 1521 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2006 | 3698 | 0.110 |
Why?
|
| Databases, Genetic | 1 | 2021 | 1756 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2008 | 3738 | 0.110 |
Why?
|
| Internet | 3 | 2021 | 3113 | 0.110 |
Why?
|
| Prescription Drugs | 1 | 2021 | 634 | 0.110 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2013 | 71 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 4 | 2014 | 3759 | 0.110 |
Why?
|
| Fas Ligand Protein | 1 | 2014 | 216 | 0.110 |
Why?
|
| Data Collection | 1 | 2022 | 3321 | 0.110 |
Why?
|
| Recombinant Proteins | 4 | 2011 | 6507 | 0.110 |
Why?
|
| G2 Phase | 2 | 2007 | 134 | 0.110 |
Why?
|
| Lymphoma | 1 | 2022 | 1899 | 0.110 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2021 | 957 | 0.110 |
Why?
|
| Observer Variation | 1 | 2019 | 2614 | 0.100 |
Why?
|
| Dexamethasone | 1 | 2020 | 1962 | 0.100 |
Why?
|
| Cloning, Molecular | 5 | 1999 | 4168 | 0.100 |
Why?
|
| Chromatin | 3 | 2001 | 2980 | 0.100 |
Why?
|
| Neuregulin-1 | 1 | 2013 | 136 | 0.100 |
Why?
|
| Sarcoma | 1 | 2024 | 1802 | 0.100 |
Why?
|
| Retinal Diseases | 1 | 2019 | 709 | 0.100 |
Why?
|
| Pyrroles | 1 | 2019 | 1121 | 0.100 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 1608 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 1198 | 0.100 |
Why?
|
| Language | 2 | 2022 | 1550 | 0.100 |
Why?
|
| Membrane Proteins | 3 | 2018 | 7869 | 0.100 |
Why?
|
| Organ Specificity | 2 | 2024 | 1968 | 0.100 |
Why?
|
| Maturation-Promoting Factor | 1 | 1992 | 26 | 0.100 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2013 | 281 | 0.100 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2012 | 440 | 0.100 |
Why?
|
| False Positive Reactions | 1 | 2014 | 958 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2020 | 1161 | 0.100 |
Why?
|
| Glucose | 1 | 2024 | 4340 | 0.100 |
Why?
|
| Potoroidae | 1 | 2011 | 7 | 0.100 |
Why?
|
| Cell Count | 1 | 2016 | 1826 | 0.100 |
Why?
|
| Decision Trees | 1 | 2013 | 508 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2020 | 2841 | 0.100 |
Why?
|
| Cyclin B | 1 | 2011 | 104 | 0.090 |
Why?
|
| Neoplasm Proteins | 3 | 2020 | 3600 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2013 | 4523 | 0.090 |
Why?
|
| Molecular Probes | 1 | 2013 | 309 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 2429 | 0.090 |
Why?
|
| Gene Expression Regulation | 6 | 2021 | 11924 | 0.090 |
Why?
|
| Liver Neoplasms | 3 | 2024 | 4356 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2019 | 3360 | 0.090 |
Why?
|
| Inflammation Mediators | 2 | 2011 | 1889 | 0.090 |
Why?
|
| Dimerization | 4 | 2014 | 882 | 0.090 |
Why?
|
| Chromosomes, Mammalian | 1 | 2011 | 148 | 0.090 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2014 | 657 | 0.090 |
Why?
|
| STAT Transcription Factors | 2 | 2023 | 189 | 0.090 |
Why?
|
| Peptides | 2 | 2020 | 4347 | 0.090 |
Why?
|
| Clone Cells | 1 | 2014 | 1670 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2018 | 1627 | 0.090 |
Why?
|
| Protein Subunits | 4 | 2007 | 940 | 0.090 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 1673 | 0.090 |
Why?
|
| Phylogeny | 3 | 2021 | 2840 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2020 | 2815 | 0.090 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2013 | 428 | 0.090 |
Why?
|
| Area Under Curve | 1 | 2014 | 1639 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2021 | 1481 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2018 | 1998 | 0.090 |
Why?
|
| Calibration | 1 | 2013 | 814 | 0.090 |
Why?
|
| Gene Dosage | 1 | 2014 | 1211 | 0.080 |
Why?
|
| Medical Oncology | 1 | 2022 | 2340 | 0.080 |
Why?
|
| Binding Sites | 3 | 2012 | 6013 | 0.080 |
Why?
|
| Transcriptional Activation | 3 | 2013 | 1751 | 0.080 |
Why?
|
| Adenosine Triphosphate | 2 | 2013 | 2001 | 0.080 |
Why?
|
| Pituitary Neoplasms | 1 | 2018 | 1324 | 0.080 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2014 | 754 | 0.080 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2019 | 1433 | 0.080 |
Why?
|
| Sequence Alignment | 3 | 2022 | 2177 | 0.080 |
Why?
|
| Apoptosomes | 1 | 2008 | 4 | 0.080 |
Why?
|
| Crystallography, X-Ray | 5 | 2016 | 1947 | 0.080 |
Why?
|
| Hair | 1 | 2013 | 508 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2018 | 1594 | 0.080 |
Why?
|
| Pain | 1 | 2024 | 5098 | 0.080 |
Why?
|
| Centromere Protein B | 1 | 2008 | 3 | 0.080 |
Why?
|
| Genes, Reporter | 2 | 2011 | 1525 | 0.080 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 1319 | 0.080 |
Why?
|
| Paraffin Embedding | 2 | 2019 | 303 | 0.080 |
Why?
|
| Caspase 9 | 1 | 2008 | 184 | 0.080 |
Why?
|
| Substrate Specificity | 2 | 2019 | 1750 | 0.080 |
Why?
|
| Glutamine | 2 | 2024 | 575 | 0.080 |
Why?
|
| Paclitaxel | 3 | 2011 | 1728 | 0.080 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 857 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1997 | 1900 | 0.070 |
Why?
|
| Formaldehyde | 2 | 2019 | 360 | 0.070 |
Why?
|
| Antibodies, Neutralizing | 2 | 2020 | 2011 | 0.070 |
Why?
|
| HCT116 Cells | 2 | 2019 | 403 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 18329 | 0.070 |
Why?
|
| Biophysical Phenomena | 2 | 2020 | 318 | 0.070 |
Why?
|
| Heterozygote | 1 | 2014 | 2795 | 0.070 |
Why?
|
| Cell Communication | 3 | 2017 | 1660 | 0.070 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 1251 | 0.070 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1991 | 792 | 0.070 |
Why?
|
| Biomedical Research | 2 | 2016 | 3459 | 0.070 |
Why?
|
| Glioma | 1 | 2022 | 3498 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 12536 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 2 | 2004 | 1326 | 0.070 |
Why?
|
| Plant Viruses | 1 | 1986 | 43 | 0.070 |
Why?
|
| Mathematics | 1 | 2008 | 696 | 0.070 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 892 | 0.070 |
Why?
|
| Nondisjunction, Genetic | 1 | 2006 | 24 | 0.070 |
Why?
|
| ROC Curve | 1 | 2014 | 3621 | 0.070 |
Why?
|
| Cells, Immobilized | 1 | 2006 | 35 | 0.070 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2009 | 415 | 0.070 |
Why?
|
| DNA Primers | 2 | 2005 | 2826 | 0.070 |
Why?
|
| Mice, Knockout | 5 | 2021 | 14473 | 0.070 |
Why?
|
| Thrombosis | 1 | 2020 | 2953 | 0.070 |
Why?
|
| Drug Therapy | 1 | 2009 | 504 | 0.070 |
Why?
|
| Metaphase | 1 | 2006 | 143 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2023 | 81657 | 0.070 |
Why?
|
| Stimulation, Chemical | 1 | 2006 | 305 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 1934 | 0.070 |
Why?
|
| Protein Biosynthesis | 1 | 2013 | 2093 | 0.060 |
Why?
|
| Molecular Imaging | 1 | 2013 | 822 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2018 | 1244 | 0.060 |
Why?
|
| beta Catenin | 1 | 2011 | 1048 | 0.060 |
Why?
|
| Receptor Cross-Talk | 1 | 2006 | 118 | 0.060 |
Why?
|
| Molecular Biology | 2 | 2010 | 573 | 0.060 |
Why?
|
| Sensitivity and Specificity | 5 | 2009 | 14653 | 0.060 |
Why?
|
| RNA Viruses | 1 | 1986 | 110 | 0.060 |
Why?
|
| Drug Approval | 1 | 2012 | 820 | 0.060 |
Why?
|
| Lamin Type A | 1 | 2006 | 186 | 0.060 |
Why?
|
| Interleukin-1 | 2 | 2006 | 1251 | 0.060 |
Why?
|
| Plasma | 1 | 2008 | 583 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2009 | 2746 | 0.060 |
Why?
|
| United States | 5 | 2021 | 72945 | 0.060 |
Why?
|
| DNA | 3 | 2002 | 7210 | 0.060 |
Why?
|
| Drug Design | 2 | 2021 | 1043 | 0.060 |
Why?
|
| Clathrin | 1 | 1986 | 258 | 0.060 |
Why?
|
| Chemokine CCL19 | 1 | 2024 | 37 | 0.060 |
Why?
|
| Membrane Potentials | 1 | 2008 | 1085 | 0.060 |
Why?
|
| Chemokine CXCL13 | 1 | 2024 | 62 | 0.060 |
Why?
|
| Hormones | 1 | 2008 | 866 | 0.060 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1987 | 393 | 0.060 |
Why?
|
| Liver | 2 | 2011 | 7571 | 0.060 |
Why?
|
| Protein Structure, Secondary | 2 | 2024 | 1211 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 1026 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 1105 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2018 | 5795 | 0.060 |
Why?
|
| Zymosan | 1 | 2024 | 134 | 0.060 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 1512 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2023 | 3157 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 2005 | 751 | 0.060 |
Why?
|
| Autoantigens | 1 | 2008 | 890 | 0.060 |
Why?
|
| Environment | 1 | 2010 | 1120 | 0.060 |
Why?
|
| Benzamides | 3 | 2018 | 1375 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2008 | 1057 | 0.060 |
Why?
|
| Growth Substances | 1 | 2006 | 759 | 0.060 |
Why?
|
| Probability | 1 | 2009 | 2476 | 0.050 |
Why?
|
| Macaca mulatta | 2 | 2020 | 2341 | 0.050 |
Why?
|
| Microfluidics | 1 | 2008 | 650 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2003 | 71 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2006 | 855 | 0.050 |
Why?
|
| ARNTL Transcription Factors | 1 | 2024 | 97 | 0.050 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2005 | 558 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2002 | 1305 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2008 | 1194 | 0.050 |
Why?
|
| Claudins | 1 | 2024 | 116 | 0.050 |
Why?
|
| Blotting, Western | 2 | 2014 | 5022 | 0.050 |
Why?
|
| Colonic Neoplasms | 2 | 2020 | 2535 | 0.050 |
Why?
|
| Neurons | 2 | 2021 | 9515 | 0.050 |
Why?
|
| Prognosis | 5 | 2022 | 29959 | 0.050 |
Why?
|
| Neoplasm Metastasis | 3 | 2021 | 4892 | 0.050 |
Why?
|
| Thrombospondin 1 | 1 | 2024 | 257 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 22351 | 0.050 |
Why?
|
| Blastocyst | 1 | 2005 | 432 | 0.050 |
Why?
|
| Multiprotein Complexes | 4 | 2012 | 1110 | 0.050 |
Why?
|
| Jurkat Cells | 2 | 2019 | 740 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2021 | 777 | 0.050 |
Why?
|
| I-kappa B Kinase | 1 | 2003 | 250 | 0.050 |
Why?
|
| Neuroimmunomodulation | 1 | 2024 | 186 | 0.050 |
Why?
|
| Models, Animal | 1 | 2008 | 2121 | 0.050 |
Why?
|
| Piperidines | 2 | 2021 | 1663 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2011 | 3401 | 0.050 |
Why?
|
| Mutagenesis | 3 | 1999 | 1228 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2023 | 253 | 0.050 |
Why?
|
| Species Specificity | 1 | 2006 | 2413 | 0.050 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2024 | 434 | 0.050 |
Why?
|
| Genome, Human | 1 | 2014 | 4443 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2022 | 412 | 0.050 |
Why?
|
| Biflavonoids | 1 | 2021 | 9 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2014 | 6613 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 1729 | 0.050 |
Why?
|
| 5'-Nucleotidase | 1 | 2022 | 163 | 0.050 |
Why?
|
| DNA Repeat Expansion | 1 | 2021 | 74 | 0.050 |
Why?
|
| Spheroids, Cellular | 1 | 2023 | 328 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 382 | 0.050 |
Why?
|
| Poly A | 1 | 2021 | 180 | 0.050 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2021 | 51 | 0.050 |
Why?
|
| Equipment Reuse | 1 | 2021 | 45 | 0.050 |
Why?
|
| Phospholipase C gamma | 1 | 2021 | 130 | 0.040 |
Why?
|
| Drug Eruptions | 1 | 2024 | 335 | 0.040 |
Why?
|
| Monocytes | 1 | 2010 | 2599 | 0.040 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2020 | 81 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2001 | 816 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2022 | 273 | 0.040 |
Why?
|
| Gene Library | 2 | 2017 | 1065 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2013 | 9661 | 0.040 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2020 | 131 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 2 | 2020 | 2039 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2024 | 65286 | 0.040 |
Why?
|
| Butadienes | 2 | 2010 | 107 | 0.040 |
Why?
|
| Janus Kinase 1 | 1 | 2020 | 108 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2024 | 876 | 0.040 |
Why?
|
| Estrogen Receptor alpha | 1 | 2024 | 581 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2003 | 1647 | 0.040 |
Why?
|
| Trans-Activators | 1 | 1989 | 2856 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2023 | 4410 | 0.040 |
Why?
|
| G1 Phase | 2 | 1999 | 403 | 0.040 |
Why?
|
| Stem Cells | 1 | 2013 | 3536 | 0.040 |
Why?
|
| Phase Transition | 1 | 2020 | 70 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 292 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2021 | 361 | 0.040 |
Why?
|
| raf Kinases | 1 | 2019 | 117 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 3 | 2013 | 6066 | 0.040 |
Why?
|
| Catalysis | 1 | 2021 | 767 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2023 | 5502 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2002 | 705 | 0.040 |
Why?
|
| Pheromones | 1 | 1999 | 93 | 0.040 |
Why?
|
| Peptide Mapping | 1 | 1999 | 259 | 0.040 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2005 | 789 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2024 | 1867 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2022 | 41706 | 0.040 |
Why?
|
| DNA Replication | 1 | 2006 | 1426 | 0.040 |
Why?
|
| Heat-Shock Response | 1 | 2020 | 179 | 0.040 |
Why?
|
| Wnt Proteins | 2 | 2014 | 722 | 0.040 |
Why?
|
| Disinfection | 1 | 2021 | 207 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2020 | 247 | 0.040 |
Why?
|
| Genes, BRCA2 | 1 | 2022 | 591 | 0.040 |
Why?
|
| Tissue Fixation | 1 | 2019 | 245 | 0.040 |
Why?
|
| Drug Repositioning | 1 | 2021 | 246 | 0.040 |
Why?
|
| Complement Activation | 1 | 2020 | 447 | 0.040 |
Why?
|
| Azaserine | 1 | 2018 | 8 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1992 | 1057 | 0.040 |
Why?
|
| Microscopy, Electron | 3 | 2005 | 2551 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2005 | 2350 | 0.040 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2020 | 268 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 13090 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 833 | 0.040 |
Why?
|
| Elasticity | 1 | 2000 | 654 | 0.040 |
Why?
|
| Indazoles | 1 | 2020 | 306 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4570 | 0.040 |
Why?
|
| Genes, BRCA1 | 1 | 2022 | 753 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2001 | 1989 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2020 | 757 | 0.040 |
Why?
|
| Mitogens | 1 | 2018 | 229 | 0.040 |
Why?
|
| Guanosine Diphosphate | 1 | 1997 | 79 | 0.040 |
Why?
|
| Phototherapy | 1 | 2021 | 368 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 949 | 0.040 |
Why?
|
| Adenosine | 1 | 2022 | 812 | 0.040 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1999 | 327 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2021 | 572 | 0.030 |
Why?
|
| Information Theory | 1 | 2017 | 49 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1990 | 2168 | 0.030 |
Why?
|
| Platelet Activation | 1 | 2020 | 643 | 0.030 |
Why?
|
| Phthalazines | 1 | 2019 | 397 | 0.030 |
Why?
|
| Nasal Mucosa | 1 | 2020 | 416 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2016 | 174 | 0.030 |
Why?
|
| Guanosine Triphosphate | 1 | 1997 | 315 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2024 | 1361 | 0.030 |
Why?
|
| Organoids | 1 | 2023 | 740 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2018 | 432 | 0.030 |
Why?
|
| Ligases | 1 | 1997 | 330 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2021 | 712 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2018 | 4143 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 2215 | 0.030 |
Why?
|
| Interferons | 1 | 2020 | 716 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 1168 | 0.030 |
Why?
|
| DNA Footprinting | 1 | 1995 | 97 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2020 | 609 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2019 | 568 | 0.030 |
Why?
|
| Endocytosis | 1 | 2020 | 951 | 0.030 |
Why?
|
| Ovary | 1 | 2020 | 963 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 904 | 0.030 |
Why?
|
| Temperature | 3 | 2007 | 2231 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2020 | 1088 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1604 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2021 | 1592 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2005 | 2858 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2011 | 414 | 0.030 |
Why?
|
| Nitriles | 2 | 2010 | 981 | 0.030 |
Why?
|
| Selection, Genetic | 1 | 1999 | 877 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 1997 | 689 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 2221 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 2571 | 0.030 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2014 | 33 | 0.030 |
Why?
|
| National Health Programs | 1 | 2017 | 443 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 39312 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2019 | 1838 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 1997 | 899 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 1560 | 0.030 |
Why?
|
| Least-Squares Analysis | 2 | 2005 | 368 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 792 | 0.030 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2016 | 257 | 0.030 |
Why?
|
| Topoisomerase Inhibitors | 1 | 2013 | 19 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2020 | 962 | 0.030 |
Why?
|
| Male | 9 | 2024 | 364154 | 0.030 |
Why?
|
| Spodoptera | 2 | 2005 | 140 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2020 | 1377 | 0.030 |
Why?
|
| Breast | 1 | 2022 | 1972 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 11062 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2020 | 1806 | 0.030 |
Why?
|
| Pyridones | 1 | 2018 | 818 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2003 | 4780 | 0.020 |
Why?
|
| Ion Channels | 1 | 2017 | 1043 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2024 | 2590 | 0.020 |
Why?
|
| Virus Replication | 1 | 2020 | 2457 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2020 | 3552 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2013 | 526 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 1994 | 326 | 0.020 |
Why?
|
| Lung | 2 | 2020 | 10068 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 4114 | 0.020 |
Why?
|
| Immobilized Proteins | 1 | 2011 | 23 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2020 | 2045 | 0.020 |
Why?
|
| Neutrophils | 1 | 2024 | 3782 | 0.020 |
Why?
|
| Time-Lapse Imaging | 1 | 2012 | 194 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 4787 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2020 | 940 | 0.020 |
Why?
|
| Movement | 1 | 1998 | 1468 | 0.020 |
Why?
|
| CDC2 Protein Kinase | 1 | 1992 | 212 | 0.020 |
Why?
|
| Viral Load | 1 | 2020 | 3385 | 0.020 |
Why?
|
| Adiposity | 1 | 2020 | 1892 | 0.020 |
Why?
|
| Computers, Molecular | 1 | 2010 | 12 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 447 | 0.020 |
Why?
|
| Finite Element Analysis | 1 | 2013 | 441 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2024 | 8728 | 0.020 |
Why?
|
| Child | 3 | 2024 | 80670 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 872 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1990 | 283 | 0.020 |
Why?
|
| Diphenylamine | 1 | 2010 | 49 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 59548 | 0.020 |
Why?
|
| Logic | 1 | 2010 | 40 | 0.020 |
Why?
|
| U937 Cells | 1 | 2010 | 260 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2010 | 102 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 378 | 0.020 |
Why?
|
| Clarithromycin | 1 | 2010 | 87 | 0.020 |
Why?
|
| Culture Media | 1 | 2012 | 893 | 0.020 |
Why?
|
| Middle Aged | 5 | 2024 | 223267 | 0.020 |
Why?
|
| Luciferases | 1 | 2011 | 713 | 0.020 |
Why?
|
| Interleukins | 1 | 2014 | 796 | 0.020 |
Why?
|
| Piperazines | 1 | 2019 | 2547 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2001 | 492 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2013 | 715 | 0.020 |
Why?
|
| Rats | 3 | 2011 | 23717 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 3213 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 3853 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 874 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2012 | 1337 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3667 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2019 | 4033 | 0.020 |
Why?
|
| Aged | 4 | 2024 | 171344 | 0.020 |
Why?
|
| Feedback | 1 | 1992 | 797 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2009 | 820 | 0.020 |
Why?
|
| Fluoroquinolones | 1 | 2010 | 307 | 0.020 |
Why?
|
| Microspheres | 1 | 2011 | 774 | 0.020 |
Why?
|
| Recurrence | 1 | 2020 | 8507 | 0.020 |
Why?
|
| Tyrosine | 1 | 1992 | 1425 | 0.020 |
Why?
|
| Antimitotic Agents | 1 | 2007 | 28 | 0.020 |
Why?
|
| Genotype | 1 | 2022 | 13036 | 0.020 |
Why?
|
| Hospitals | 1 | 2020 | 3885 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1986 | 297 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 2510 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12826 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 2561 | 0.020 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2007 | 196 | 0.020 |
Why?
|
| Oocytes | 1 | 2011 | 1168 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2006 | 134 | 0.020 |
Why?
|
| Education | 1 | 2008 | 531 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 2198 | 0.020 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2005 | 134 | 0.020 |
Why?
|
| Crystallization | 1 | 1986 | 518 | 0.020 |
Why?
|
| Genes, ras | 1 | 2007 | 656 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 5753 | 0.010 |
Why?
|
| Multigene Family | 1 | 2007 | 1081 | 0.010 |
Why?
|
| Brain | 2 | 2021 | 27158 | 0.010 |
Why?
|
| Capsid | 1 | 1986 | 435 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3803 | 0.010 |
Why?
|
| Cricetinae | 1 | 1987 | 2416 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2016 | 3582 | 0.010 |
Why?
|
| Immunoassay | 1 | 2006 | 744 | 0.010 |
Why?
|
| Buffers | 1 | 2002 | 141 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15912 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2004 | 258 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 2010 | 987 | 0.010 |
Why?
|
| Plasmids | 1 | 1987 | 2268 | 0.010 |
Why?
|
| Surface Properties | 1 | 2005 | 1153 | 0.010 |
Why?
|
| Solutions | 1 | 2002 | 405 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2020 | 5193 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1986 | 2478 | 0.010 |
Why?
|
| Europe | 1 | 2008 | 3430 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 1991 | 1705 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 2801 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2002 | 655 | 0.010 |
Why?
|
| Electrons | 1 | 2002 | 264 | 0.010 |
Why?
|
| Pyridines | 1 | 2012 | 2888 | 0.010 |
Why?
|
| Biological Assay | 1 | 2003 | 626 | 0.010 |
Why?
|
| Pregnancy | 1 | 2022 | 30236 | 0.010 |
Why?
|
| Micrococcal Nuclease | 1 | 1999 | 36 | 0.010 |
Why?
|
| Transfection | 1 | 2007 | 5755 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 9546 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 11218 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2006 | 1730 | 0.010 |
Why?
|
| RNA, Viral | 1 | 1986 | 2867 | 0.010 |
Why?
|
| Galactose | 1 | 1999 | 299 | 0.010 |
Why?
|
| Peptide Library | 1 | 1999 | 351 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1997 | 645 | 0.010 |
Why?
|
| Lipoproteins | 1 | 1999 | 871 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 59939 | 0.010 |
Why?
|
| Tubulin | 1 | 1997 | 694 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 12064 | 0.010 |
Why?
|
| Polymers | 1 | 1997 | 1624 | 0.010 |
Why?
|
| Sepsis | 1 | 2003 | 2604 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 9244 | 0.000 |
Why?
|
| Adult | 1 | 2020 | 223305 | 0.000 |
Why?
|